Carregant...

Insights into the pathogenesis of Langerhans cell histiocytosis: the development of targeted therapies

More than a century after its first description, Langerhans cell histiocytosis (LCH) still remains an intriguing disease. Considerable progress in understanding its biology has been achieved recently. Description of the V600E BRAF mutation in samples of LCH tissue in 2010 was followed by description...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Immunotargets Ther
Autors principals: Hutter, Caroline, Minkov, Milen
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2016
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5066850/
https://ncbi.nlm.nih.gov/pubmed/27785447
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/ITT.S91058
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!